Skip to main content
Canagliflozin reduces total CV burden in T2D patients with CKD
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Canagliflozin reduces total CV burden in T2D patients with CKD
User login
Username
Password
Reset your password
Concept
Lead
score
Type 2 Diabetes Mellitus
1
1
Chronic Kidney Disease
0
0.93
Cardiovascular disease
0
0.85
Hemoglobin A1c
0
0.39
Hemoglobin
0
0.28
Specialty
Lead
score
Diabetes & Endocrinology
1
1
Family Medicine/Primary Care
0
1
Internal Medicine
0
1
Nephrology
0
1
Cardiology
0
0.55
Edit Tags